We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

45 hedge funds and large institutions have $3.34M invested in Applied Genetic Technologies Corporation in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

4% less funds holding

Funds holding: 47 → 45 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

61% less capital invested

Capital invested by funds: $8.49M → $3.34M (-$5.16M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
11
Reduced
12
Closed
10
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$70K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
+$535K
2
Renaissance Technologies
Renaissance Technologies
New York
+$363K
3
Citadel Advisors
Citadel Advisors
Florida
+$185K
4
Wells Fargo
Wells Fargo
California
+$78.9K
5
CG
Colony Group
Massachusetts
+$49K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$625K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$220K
3
BCM
Bridgeway Capital Management
Texas
-$120K
4
KCM
Knoll Capital Management
Florida
-$77K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$67K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Portolan Capital Management
Massachusetts
$435K -$2.05K -4,697 -0.3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$401K -$220K -503,929 -25%
Millennium Management
3
Millennium Management
New York
$395K -$18.9K -43,242 -3%
IVM
4
InterWest Venture Management
California
$381K – – –
KCM
5
Kingdon Capital Management
New York
$333K +$535K +1,225,000 New
Renaissance Technologies
6
Renaissance Technologies
New York
$309K +$363K +831,768 +272%
BlackRock
7
BlackRock
New York
$249K -$2.43K -5,564 -0.6%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$188K +$6.68K +15,297 +2%
CG
9
Colony Group
Massachusetts
$120K +$49K +112,332 +34%
Citadel Advisors
10
Citadel Advisors
Florida
$115K +$185K +423,709 New
Wells Fargo
11
Wells Fargo
California
$70K +$78.9K +180,630 +236%
State Street
12
State Street
Massachusetts
$34K – – –
VF
13
Virtu Financial
New York
$32K +$46.1K +105,681 +978%
Ameriprise
14
Ameriprise
Minnesota
$31K -$4.1K -9,400 -8%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$30K -$67K -153,375 -59%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$28K +$26.5K +60,700 +138%
Stifel Financial
17
Stifel Financial
Missouri
$25K +$4.15K +9,500 +12%
Two Sigma Investments
18
Two Sigma Investments
New York
$22K +$35.1K +80,397 New
Northern Trust
19
Northern Trust
Illinois
$20K – – –
UBS Group
20
UBS Group
Switzerland
$16K +$20.5K +46,971 +398%
Assenagon Asset Management
21
Assenagon Asset Management
Luxembourg
$15K +$8.66K +19,838 +55%
Morgan Stanley
22
Morgan Stanley
New York
$14K +$5.3K +12,137 +31%
FT
23
Fiduciary Trust
Massachusetts
$11K – – –
KAS
24
Kestra Advisory Services
Texas
$9K -$218 -500 -1%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$8K – – –
1
2

AGTC Hedge Fund Activity: Q3 2022 in Review

45 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2022, worth a combined $3.34M — down 61% from $8.49M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AGTC and 8 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was Kingdon Capital Management, opening a new position worth an estimated $535K. The largest seller was Sabby Management, exiting entirely with an estimated $625K sold.

  • 45 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2022, down from 47 in Q2 2022.
  • Funds reported $3.34M of Applied Genetic Technologies Corporation stock for Q3 2022, down 61% quarter-over-quarter.
  • 8 funds opened new Applied Genetic Technologies Corporation positions in Q3 2022 and 10 closed out, a net change of -2 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q3 2022 was Kingdon Capital Management, an estimated $535K added.
  • The largest Applied Genetic Technologies Corporation seller in Q3 2022 was Sabby Management, an estimated $625K sold.

Based on aggregated 13F filings for Q3 2022.